Blog

Justin Stebbing: Five ways to cut your risk of cancer – by an oncology consultant

Justin Stebbing/healthpost.in

Dec 20, 2024, 17:28

Justin Stebbing: Five ways to cut your risk of cancer – by an oncology consultant

Cancer is one of the leading causes of illness and death worldwide, but understanding its risk factors is key to prevention and early detection.

While some risks, like genetics, are beyond our control, many lifestyle and environmental factors can significantly impact your chances of developing cancer. From diet and physical activity to exposure to carcinogens and lifestyle choices like smoking or alcohol use, knowing what increases your risk is the first step toward making healthier decisions.

Justin Stebbing, Visiting Professor of Cancer Medicine and Oncology at Imperial College, recently shared a post on The Conversation about five evidence-based strategies to help reduce your chances of developing cancer:

“Cancer is a complex disease with many causes – and sometimes none. For some patients, getting cancer is down to plain bad luck.

As an oncology consultant, I see many cases where patients are otherwise perfectly healthy and have followed a healthy lifestyle. Nevertheless, research has shown there are several ways to reduce your risk. Here are five evidence-based strategies to help lower your chances of developing cancer:

1. Quit smoking and avoid tobacco

2. Maintain a healthy weight and stay physically active

3. Adopt a healthy diet

4. Limit alcohol consumption

5. Protect against sun exposure and get vaccinated.”

Justin Stebbing: Five ways to cut your risk of cancer – by an oncology consultant TeodorLazarev/Shutterstock

Read full article at theconversation.com

Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011. He is a scientific advisor at Sable Bio.

Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.